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Abstract.
Purpose: To improve the delivery efficiency of VMAT by extending the recently
published VMAT treatment planning algorithm vmerge to automatically generate
optimal partial-arc plans.
Methods and materials: A high-quality initial plan is created by solving a convex
multicriteria optimization problem using 180 equi-spaced beams. This initial plan is
used to form a set of dose constraints, and a set of partial-arc plans is created by
searching the space of all possible partial-arc plans that satisfy these constraints. For
each partial-arc, an iterative fluence map merging and sequencing algorithm (vmerge)
is used to improve the delivery efficiency. Merging continues as long as the dose quality
is maintained above a user-defined threshold. The final plan is selected as the partial-
arc with the lowest treatment time. The complete algorithm is called pmerge.
Results: Partial-arc plans are created using pmerge for a lung, liver and prostate
case, with final treatment times of 127, 245 and 147 seconds. Treatment times using
full arcs with vmerge are 211, 357 and 178 seconds. Dose quality is maintained across
the initial, vmerge, and pmerge plans to within 5% of the mean doses to the critical
organs-at-risk and with target coverage above 98%. Additionally, we find that the
angular distribution of fluence in the initial plans is predictive of the start and end
angles of the optimal partial-arc.
Conclusions: The pmerge algorithm is an extension to vmerge that automatically
finds the partial-arc plan that minimizes the treatment time. VMAT delivery efficiency
can be improved by employing partial-arcs without compromising dose quality. Partial-
arcs are most applicable to cases with non-centralized targets, where the time savings
is greatest.
Keywords: VMAT, treatment planning, partial-arcs, delivery efficiency
PACS numbers: 87.55.D-, 87.55.de
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1. Introduction
Volumetric modulated arc therapy (VMAT) is an extension to intensity modulated
radiation therapy (IMRT) that offers the ability to deliver highly conformal dose
distributions in a fraction of the time as IMRT (Yu & Tang 2011). In both techniques,
the delivered radiation is modulated by a multi-leaf collimator (MLC) that conforms the
dose to the targets. However, unlike IMRT where radiation is delivered at a fixed set
of beam angles, in arc therapy the gantry delivers radiation continuously as it moves in
an arc around the patient. In VMAT, one of the more widely used forms of arc therapy,
the gantry speed, dose rate, and MLC leaf positions are allowed to vary as the gantry
moves around the couch (Otto 2008). The additional degrees of freedom afforded by
VMAT have been shown to maintain or improve the dose conformity when compared
with IMRT (Teoh et al. 2011, Palma et al. 2008, Cozzi et al. 2008, Johnston et al. 2011).
However, this also makes the treatment planning process much more complex.
One of the most compelling reasons for using VMAT over IMRT is the ability to
reduce the treatment time, often below 5 minutes per session (Bedford 2009, Clivio
et al. 2009, Rao et al. 2010, Zhang et al. 2010). Reducing treatment time and the
number of monitor units delivered reduces errors from patient motion (Hoogeman
et al. 2008), decreases the scattered dose responsible for secondary malignancies (Hall
& Wuu 2003, Ruben et al. 2008, Kry et al. 2005), and may have direct radiobiological
benefits (Wang et al. 2003, Bese et al. 2007). In addition, it reduces the amount of time
patients need to spend receiving their therapy, and may allow for the treatment of more
patients.
Approaches in reducing treatment time have focused on, for example, optimizing the
delivery parameters (e.g. dose rate) given an initial plan (Rangaraj et al. 2010, Boylan
et al. 2011), improving the delivery control system (Bertelsen et al. 2011) and developing
leaf sequencing algorithms that improve delivery efficiency (Luan et al. 2008). In our
own work on VMAT, we introduced vmerge, a method to facilitate the selection of
the best balance between planning objectives and delivery efficiency, one of the main
tradeoffs in VMAT treatment planning (Craft et al. 2012). Inherent to most approaches
is the idea that in the tradeoff between dose quality and delivery efficiency, dose quality
should be highly favored.
Arc therapy can be delivered as a partial-arc, a full single arc, or as multiple arcs.
For complex cases where a large amount of beam modulation is required, delivery in a
single arc requires significant slowing of the gantry and reduction of the dose rate to
achieve dose distributions similar to IMRT (Bortfeld & Webb 2009). Instead, radiation
may be delivered over multiple arcs, which provides the necessary degrees of freedom
but will tend to increase the total treatment time and required number of monitor
units (Guckenberger et al. 2009). Alternatively, for cases with peripherally located
targets, one might expect that appreciable beam modulation is only required over a
critical angle range. In this case, the gantry might move at maximal speed and with small
aperture sizes over the angles that do not provide for effective radiation. Eliminating
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this portion of the arc from the delivery would be expected to reduce the treatment time
with minimal effect on the dose distribution. However, to the best of our knowledge, no
VMAT algorithm explicitly addresses this situation. In this work, we present a method
called pmerge for automatically finding the optimal partial-arcs that eliminate the
unneeded arc segments without significantly compromising dose quality.
Like the beam angle optimization problem for fixed beam IMRT, the partial-arc
optimization problem is nonconvex. Nonconvexity means that a local minimum is not
guaranteed to be a global minimum. In order to guarantee a global minimum for
nonconvex problems, a global search needs to be performed. Given that the nonconvex
space of the partial-arc optimization problem consists of only two variables, the start
and end gantry angles, this global search can be done by discretizing the search space
and enumerating all possible start/end angle pairs, which is the strategy we adopt. This
strategy is inherently parallelizeable, allowing for shorter computation times.
To solve the VMAT problem for each partial-arc we use our previously reported
merging and sequencing algorithm called vmerge (Craft et al. 2012). We call
the complete process pmerge, which employs both merging and sequencing and an
enumerable set of partial-arcs to reduce treatment time. Given an initial high quality
plan as a dose “gold standard”, pmerge will automatically determine the fluence
maps, dose rate, gantry speed, and starting and ending gantry angles that minimize
the treatment time while maintaining the dose distribution to within a user-defined
quality threshold.
2. Materials and methods
We define the following terms: initial plan, partial-arc plan, planning goals, vmerge
plan and pmerge plan. The initial plan refers to a high-quality plan that serves as the
dose standard used to constrain all partial-arcs. The initial plan is created without
regards to delivery efficiency, providing a standard for understanding the tradeoff
between dose quality and delivery efficiency. Our strategy for creating the initial plan
is described in Section 2.2, where we define a 180-beam IMRT problem, with beams
placed every 2◦, and solve it using multi-criteria optimization (MCO).
Next, a set of partial-arc plans is created using a two-step process. First, we solve
a set of restricted angle IMRT problems with various start and end gantry angles,
with beams placed every 2◦, by finding feasible solutions that minimize the sum-of-
positive gradients (SPG), subject to matching the initial dose quality (Section 2.3). We
then use vmerge to iteratively merge neighboring fluence maps to create deliverable
VMAT plans with improved delivery efficiency. Merging is automatically halted when
the merged plan violates a set of user-defined planning goals, which articulates how
much the planner is willing to deviate from the initial plan in order to improve delivery
efficiency. We refer to the vmerge plan as the result of the merging algorithm on
the 180-beam plan, and the pmerge plan as the merged partial-arc with the lowest
treatment time. The full method is outlined in Figure 1.
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Figure 1. Illustration of our three step process. 1) An initial IMRT plan is created to
generate a set of dose constraints for pmerge. 2a) pmerge uses these constraints to
generate a set of partial-arc solutions. 2b) Each N -beam partial-arc solution is merged
and sequenced with vmerge, subject to the user-defined planning goals. 3) The final
plan is selected as the one with the lowest treatment time.
2.1. Delivery parameters and leaf sequencing
There are two classes of methods for solving VMAT problems: one-stage and two-
stage (Yu & Tang 2011). In the one stage method, known as direct aperture optimization,
the paths of the MLC leaves are directly optimized, taking into account limitations of
finite leaf speed. Instead, we use a two-stage planning approach to solve the VMAT
problem for any size arc. In the first step, an N -beam IMRT problem with beams
spaced every 2◦ is solved to generate a set of N fluence maps (f 1l,x, f
2
l,x..., f
N
l,x), where
each fluence map is a K×L matrix of L rows of MLC leaves and K columns. In the
second step, a leaf sequencing algorithm determines the MLC leaf trajectories, gantry
speed (ω), and dose rate (r) for each 2◦ arc portion, which we call a gantry sector. In
leaf sequencing, the trajectories of the leaves are set so that the accumulated fluence
over a given gantry sector matches the input fluence from the static beam fluence map.
To accomplish this, we employ a widely used dynamic MLC (dMLC) sequencer which
creates a “sliding window” that moves leaves unidirectionally across the field for each
arc portion (Spirou & Chui 1994, Svensson et al. 1994). Thus, for each gantry sector, the
leaves must move from left-to-right (or right-to-left), traversing the entire field of width
W . In practice, the gantry speed, dose rate and maximum leaf speed are constrained
by the limitations of the linac hardware and will have a significant effect on the total
treatment time (Boylan et al. 2011). We select a set of hardware capabilities (Table 1)
that are representative of the values found on many current treatment machines.
When applied to VMAT, the total treatment time using the dMLC algorithm is
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Table 1. VMAT delivery parameters and constraints
Delivery parameter Symbol Constraint
Maximum leaf speed vmax 2.5 cm/s
Maximum gantry speed ωmax 6 deg/s
Minimum gantry speed ωmin 0 deg/s
Maximum dose rate rmax 600 MU/min
Minimum dose rate rmin 50 MU/min
controlled by three terms: 1) the total distance the leaves must travel during delivery,
2) the amount of beam modulation required to deliver the desired fluence map and 3)
the maximum gantry speed. These three considerations can be combined to provide an
equation to calculate the total treatment time for a plan with N gantry sectors of arc
lengths ∆θi:
T =
N∑
i=1
max


W
vmax
+
max
rows l
[
K∑
x=1
(
df il,x(x)
dx
)+]
ri
,
∆θi
ωmax

 (1)
where the (.)+ operator is shorthand for max (0, .). The first term in (1) is the field
width divided by the maximum leaf speed, which is the minimum time required for the
leaves to move from the left side of the field to the right (or vice versa) if no fluence
were delivered. As fluence is added, the leaf speed will be modulated to allow enough
time for the dose to accumulate. This time is described in the second term as the
sum-of-positive gradients (SPG), a measure of the amount of variation in a field (Craft
et al. 2007), divided by the dose rate. Fields that are highly varied (have a high SPG
term) will take longer to deliver with dMLC. Finally, because of limitations on the
maximum gantry speed, the time required to deliver a gantry sector cannot be less than
time required to move the gantry at maximum speed over the gantry sector. The total
treatment time is the sum of the time required to deliver each of the N gantry sectors.
Given a fixed set of hardware capabilities, the total treatment time can be improved
by either decreasing the total number of gantry sectors N or by decreasing the SPG.
Decreasing the number of gantry sectors motivates the partial-arc strategy described
here, and the merging strategy vmerge – by using partial-arc solutions, we begin with
a lower number of fluence maps than in a full arc, and this is decreased further by
combing gantry sectors in the merging routine. Thus, for each gantry sector that is
merged or eliminated with a partial-arc, the treatment time decreases by no less than
W/vmax. Finally, to further reduce treatment time, we incorporate SPG minimization
into our optimization step as described in Section 2.3.
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2.2. Initial plan optimization
We use a multicriteria optimization (MCO) approach to solve the initial 180-beam IMRT
problem, as described in Craft et al. (2012). Briefly, in MCO, each structure is assigned
an objective function, and a tradeoff surface of Pareto optimal plans is generated by
the optimizer (Monz et al. 2008, Thieke et al. 2007). A Pareto optimal plan is one
where no improvements could be made to any objective without worsening another
objective (Cotrutz et al. 2001). The user navigates this tradeoff surface and selects the
plan that best meets the treatment goals.
The general multicriteria IMRT formulation is the following:
optimize {g1(d), g2(d), . . . gM(d)}
subject to d = Df
d ∈ C
f ≥ 0 (2)
where gi are theM objective functions describing the dose to a particular structure (e.g.,
mean dose to stomach), d is the vector of voxel doses, D is the dose-influence matrix,
and f is a concatenation of all the fluence maps into a single beamlet fluence vector.
The set C is a convex set of dose constraints (e.g. maximum dose to the target) that are
designed to be met by all plans. We use the CERR 3.0 (Deasy et al. 2003) environment
and its beamlet based quadratic infinite beam (QIB) dose computation to calculate the
dose influence matrix, with a computation time of around 10 minutes per case. Given a
dose matrix, the dose distribution can be calculated from the fluence maps in seconds.
The constraints on the planning target volumes (PTV) and the OARs for each site
are listed in Table 2. In our MCO formulation, we had the optimizer minimize the
mean doses to the OARs. Additionally, we include as an OAR unclassified tissue (u.t.),
which encompasses all voxels that do not belong to another structure. Optimizations are
performed using the solver described by Chen et al. (2010). We then choose a plan for
each treatment site by exploring the Pareto surface and selecting a plan that balanced
the dose the OARs.
Table 2. Target coverage constraints and OAR list used in the MCO optimization
Treatment site PTV Min; Max (Gy) OARs
Lung 50.0; 55.0 left lung, right lung, esophagus,
heart, spinal cord, u.t.
Liver 50.0; 55.0 left lung, right lung, liver, spinal cord,
stomach, left kidney, right kidney, u.t.
Prostate 79; 85.3 left femoral head, right femoral head,
anterior rectum, bladder, u.t.
Optimal partial-arcs in VMAT treatment planning 7
2.3. Generating the partial-arc plans
The set of partial-arc solutions are created by iteratively solving the 2◦ grid IMRT
problem for a range of partial-arcs. In creating the plans, we respect the constraint
that the gantry cannot rotate through 0◦, a line from the couch to the floor. Plans are
created with arc lengths every 40◦ (360◦, 320◦, ...) until there are no feasible solutions.
For each arc length, plans are created with arcs centered at intervals of 40◦. Thus, there
is one 360◦ plan, three 320◦ degree plans (beginning at −40◦, 0◦, 40◦), five 280◦ plans,
etc.
Each partial-arc solution is created to maintain the same dose quality as the initial
180-beam solution. This is done with the same solver used to solve the original 180-
beam MCO formulation, except run in feasibility mode, where the solver returns the
first solution it finds which satisfies all of the hard constraints. Because treatment time
scales with the complexity of the solution, this solution is then smoothed using total
SPG as the objective function, while maintaining dosimetric feasibility:
SPG minimization subject to dose matching
minimize
N∑
i=1
max
rows l
[
K∑
x=1
(
df il,x(x)
dx
)+]
subject to d = Df
di ≥ BL, ∀i ∈ target
di ≤ BU , ∀i
mean
(P )
j (d) ≤ mean
(I)
j (d), ∀ OAR j
f ≥ 0 (3)
where BL and BU is the target lower bound, BU is the upper bound on the dose, and
mean
(P )
j (d) and mean
(I)
j (d) are the mean doses to the jth OAR for the partial-arc and
initial plans, respectively. This formulation ensures that for each partial-arc solution
the target coverage is no less than, and the maximum dose and the mean doses to each
OAR are no greater than those of the initial plan.
2.4. Merging and final plan selection
After the SPG minimization step, we have a set of IMRT solutions for various partial-
arcs. To improve the delivery efficiency, we use a previously described fluence map
merging strategy called vmerge to combine gantry sectors (Craft et al. 2012). Briefly,
vmerge employs a greedy merging strategy to iteratively add similar neighboring
fluence maps – for each iteration, the two neighboring fluence maps that are most
similar are added together into a single fluence map. This reduces the number of gantry
sectors and improves the delivery efficiency, at the expense of reducing the amount of
fluence modulation and the angular resolution.
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pmerge automates vmerge by utilizing a quality cutoff, which limits how much
the dose can change, and automatically stops merging when the quality drops below the
planning goals. Here, the planner is free to chose how much the dose quality is allowed
to change in order to improve delivery efficiency. We use the initial high-quality plan
as a guide for how to set these goals. For the OARs that receive the most radiation, we
limit the partial-arc mean dose to less than 105% of the initial mean dose for that OAR.
Additionally, we ensure that the target coverage stays above 98%, and the maximum
dose is less than 102% of the initial maximum dose. Finally, we illustrate the use of
site-specific planning goals, including limiting the maximum dose to the femoral heads
in the prostate case and adding additional constraints on the left lung dose in the lung
case. The full sets of planning goals are provided in Tables 3-5.
3. Results
3.1. Lung
Table 3. Lung: Planning goals, dose quality and treatment times
Goal Initial (I) pmerge (P)
u.t. dose mean
(P )
UT < 1.10×mean
(I)
UT 2.8 Gy 3.0 Gy
Right lung mean
(P )
RL < 1.05×mean
(I)
RL 0.6 Gy 0.5 Gy
Left lung †V 40(P ) < 1.05× V 40(I) 9.4% 9.5%
V 50(P ) < 1.05× V 50(I) 3.0% 3.0%
Target coverage V 50(P ) > 0.98× V 50(I) 100% 98.2%
Maximum dose max(P ) < 1.02×max(I) 55.0 Gy 55.8 Gy
(Start, end) angles (0◦, 360◦) (60◦, 260◦)
Treatment time‡ 211 s 127 s
†Vx denotes the volume receiving at least x Gy
‡Treatment times are after merging
We navigate to an initial 180-beam plan with mean doses and target coverage as
shown in Table 3. The treatment time of the initial plan before merging is 771 s, and
is reduced to 211 s with vmerge. The initial plan and vmerge plans are shown with
the outer two rings of Fig 2(c). The vmerge plan is notable for a large arc portion of
116◦ on the contralateral side of the PTV where the gantry speed is at its maximum.
As shown in Figure 2(d), there is little fluence delivered over this section in the initial
180-beam plan.
Partial-arc solutions were attempted for arcs with lengths between 80◦ and 360◦, at
intervals of 40◦. 50 had feasible solutions that met the dose constraints from Equation 3,
and 26 of these had lower treatment times than the vmerge plan. The final pmerge
plan has an arc length of 200◦ and treatment time of 127 s, and is shown in the inner
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two rings of Fig 2c, both before and after merging. The total difference in treatment
times between the vmerge (211 s) and pmerge (127 s) plans is 84 s, a 40% reduction.
Optimization, merging and sequencing took about 40 minutes to complete all 64 plans,
running in parallel on 8 processors. Computation time was similar across the lung, liver
and prostate cases.
3.2. Liver
Table 4. Liver: Planning goals, dose quality and treatment times
Goal Initial (I) pmerge (P)
u.t. mean
(P )
UT < 1.10×mean
(I)
UT 5.7 Gy 5.6 Gy
Right lung mean
(P )
RL < 1.05×mean
(I)
RL 9.1 Gy 9.2 Gy
Left lung no constraint (mean
(P )
LL ) 1.5 1.5 Gy
Liver mean
(P )
L < 1.05×mean
(I)
L 23.3 Gy 23.3 Gy
Right kidney mean
(P )
RK < 1.05×mean
(I)
RK 5.8 Gy 4.7 Gy
Left kidney no constraint (mean
(P )
LK) 0.7 Gy 0.4 Gy
Target coverage V 50(P ) > 0.98× V 50(I) 100% 98.0%
Maximum dose max(P ) < 1.02×max(I) 55.0 Gy 55.6 Gy
(Start, end) angles (0◦, 360◦) (100◦, 340◦)
Treatment time† 357 s 245 s
†Treatment times are after merging
We navigate to an original 180-beam solution with mean OAR doses, target
coverage and maximum dose as shown in Table 4. The treatment time before merging
for the full arc solution is 1214 s and is reduced to 357 s with vmerge (Figure 3(c),
outer rings). Partial-arc solutions were attempted for arcs lengths between 80◦ and
360◦, at intervals of 40◦, and 33 had feasible solutions. There were no solutions with arc
lengths less than 160◦. Of the feasible partial-arcs, 19 had lower treatment times than
the vmerge plan.
The selected partial-arc has an arc length of 240◦ (Figure 3(c), inner rings) and
treatment time of 245 s. The total difference in treatment times between the vmerge
plan (357 s) and pmerge plan (245 s) is 112 s, a 31% reduction. In this case the initial
180-beam solution is significant for two peaks of fluence, one at approximately 150◦ and
one at 330◦, as shown in Figure 3(d). The optimal partial-arc includes both of these
peaks, and is able to eliminate the first 100◦ where the amount of required fluence is
low.
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Table 5. Prostate: Planning goals, dose quality and treatment times
Goal Initial (I) pmerge (P)
u.t. mean
(P )
UT < 1.10×mean
(I)
UT 15.5 Gy 16.4 Gy
Anterior rectum mean
(P )
AR < 1.05×mean
(I)
AR 41.4 Gy 41.8 Gy
Bladder mean
(P )
B < 1.05×mean
(I)
B 39.6 Gy 39.8 Gy
Left femoral head max
(P )
LFH < 1.10×max
(I)
LFH 33.6 Gy 35.5 Gy
Right femoral head max
(P )
RFH < 1.10×max
(I)
RFH 37.0 Gy 38.3 Gy
Target coverage V 79(P ) > 0.98× V 79(I) 100% 98.2%
Maximum dose max(P ) < 1.02×max(I) 85.3 Gy 86.7 Gy
(Start, end) angles (0◦, 360◦) (40◦, 320◦)
Treatment time† 178 s 147 s
†Treatment times are after merging
3.3. Prostate
We navigated to an original 180-beam solution with mean OAR doses, target coverage
and maximum dose as shown in Table 5. The treatment time before merging for the full
arc solution is 860 s and is reduced to 178 s with vmerge (Figure 4(c), outer two rings).
Unlike the lung and liver cases, the vmerge plan has regularly spaced arc portions of
similar size, and the fluence is delivered fairly uniformly around the target, as shown in
Figure 4(d). This is reflected in the optimal partial-arc solution, which is highly similar
to the initial plan through nearly the full arc.
Partial-arc solutions were created for arcs lengths between 80◦ and 360◦, at intervals
of 40◦, and 45 had feasible solutions. Of the 45, only 3 had treatment times lower
than the vmerge plan. There were no feasible partial-arcs at 80◦. For plans with
arc lengths of less than 280◦, almost no merging was possible before the plan quality
degraded beyond the stopping criteria. The selected partial-arc has an arc length of
300◦ (Figure 4(c), inner rings) and treatment time of 147 s. The total difference in
treatment times between the vmerge (178 s) plan and pmerge plan (147 s) is 31 s, a
17% reduction.
4. Discussion and conclusions
We present a method for automatically creating efficient VMAT partial-arc plans from
a high quality reference plan. By sampling a set of partial-arcs, we reduced treatment
times for a lung, liver and prostate case. The final pmerge plans reflect the underlying
geometry of the problem. For the lung and liver cases with non-centralized PTVs, a
signifiant portion of the full-arc can be eliminated with little effect on the dose quality.
This allowed for the treatment time to be reduced by 40% and 31% respectively. The
reduction in treatment time for the prostate case was more modest at 17%. As might be
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expected for a centrally located target, the fluence was distributed more evenly around
the arc, and most of the partial-arcs were not able to improve the delivery efficiency
while maintaining the dose quality to within the specified boundaries.
In pmerge, the dose quality of the final partial-arc is designed to be highly similar
to the initial plan. However, the pmerge plan is limited only by the planning goals
specified after the initial plan creation. Thus, the partial-arc plan could deviate from
the initial plan in ways that are not specified by this quality threshold. Any number
or type of constraints could easily be imposed on the final solution to ensure that the
initial plan and pmerge plan were sufficiently similar. In practice, we did not find that
it was necessary to impose many constraints in order to match the solutions. Although
we were free to use any number of dose-volume points or EUD functions, our planning
goals were restricted to only one or two constraints per OAR, usually a limit on the
mean or maximum dose. For all three cases, these were sufficient to closely match the
doses across the DVH, even for OARs which were not explicitly specified.
In VMAT, as in IMRT, there are many different ways to deliver the fluence that
will give highly similar dose distributions. Because the treatment time is dependent
on the geometry of these fluence maps, the method by which the initial fluence maps
are created is an important determinant of treatment time. Although pmerge is not
confined to any single optimization strategy, we found that using SPG smoothing was
critically important to achieving highly efficient plans. Indeed, fluence map smoothing is
important in IMRT (e.g. (Matuszak et al. 2008)), where it is know that the complexity
of the fluence maps – and hence the number of monitor units – can be greatly reduced
without significantly impacting the dose distribution.
Although the partial-arc global search can be parallelized, we recognize that the
high computation time is a limit to our method. The observation that the optimizer
distributes fluence very similarly between the full-arc and partial-arc plans suggests a
way of approximating the appropriate partial-arc without having to enumerate all of the
possibilities. One strategy would be to plot the arrangement of fluence around the arc
and have the planner select the partial-arc that captures the critical angles. For the lung
and liver cases, we find that there were many different partial-arcs that greatly improved
the treatment time, and thus it is not essential to find the absolute global minimum
when plans near the minimum are almost equivalent (see Figures 2(a) and 3(a)). More
importantly, we conclude that partial-arcs that cover certain critical angles are useful
for reducing treatment time in VMAT, and pmerge is a useful first-pass method at
finding the optimal plan.
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Figure 2. Lung: a) Final treatment times for each of the merged partial-arc plans
(blue squares) with treatment times near or below the vmerge plan (red circle). b)
DVH for the initial 180-beam plan (solid) and the pmerge plan (dashed). c) Initial
and merged gantry sectors for the pmerge plan (inner rings) and 180-beam plan (outer
rings) over the pmerge dose wash. d) Distribution of fluence for the initial solution
and the optimal partial-arc before merging (100-beam).
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Figure 3. Liver: a) Final treatment times for each of the merged partial-arc plans
(blue squares) with treatment times near or below the vmerge plan (red circle). b)
DVH for the initial 180-beam plan (solid) and the pmerge plan (dashed). c) Initial
and merged gantry sectors for the pmerge plan (inner rings) and 180-beam plan (outer
rings) over the pmerge dose wash. d) Distribution of fluence for the initial solution
and the optimal partial-arc before merging (120-beam).
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Figure 4. Prostate: a) Final treatment times for each of the merged partial-arc
plans (blue squares) with treatment times near or below the vmerge plan (red circle).
b) DVH for the initial 180-beam plan (solid) and the pmerge plan (dashed). c) Initial
and merged gantry sectors for the pmerge plan (inner rings) and 180-beam plan (outer
rings) over the pmerge dose wash. d) Distribution of fluence for the initial solution
and the optimal partial-arc before merging (140-beam).
